Shortage of Zypadhera (olanzapine)
Submitted by Anonymous (not verified) on 9 July 2024 - 9:23
Shortage of Zypadhera (olanzapine)
Member states contact points for translations review
Submitted by Anonymous (not verified) on 9 July 2024 - 9:21
Member states contact points for translations review
Fifth European Medicines Agency (EMA) and the Association of the European Self-Medication Industry (AESGP) bilateral meeting, Online, European Medicines Agency, Amsterdam, the Netherlands, from 29 April 2024, 10:00 (CEST) to 29 April 2024, 12:00 (CEST)
Submitted by Anonymous (not verified) on 9 July 2024 - 8:32
Fifth European Medicines Agency (EMA) and the Association of the European Self-Medication Industry (AESGP) bilateral meeting, Online, European Medicines Agency, Amsterdam, the Netherlands, from 29 April 2024, 10:00 (CEST) to 29 April 2024, 12:00 (CEST)
Agenda - Fifth EMA-AESGP annual bilateral meeting
Submitted by Anonymous (not verified) on 9 July 2024 - 8:30
Agenda - Fifth EMA-AESGP annual bilateral meeting
Highlights from the fifth European Medicines Agency (EMA) and the Association of the European Self-Medication Industry (AESGP) bilateral meeting
Submitted by Anonymous (not verified) on 9 July 2024 - 8:25
Highlights from the fifth European Medicines Agency (EMA) and the Association of the European Self-Medication Industry (AESGP) bilateral meeting
Article 57 product data
Submitted by Anonymous (not verified) on 9 July 2024 - 8:24
Article 57 product data
QRD Appendix V - Adverse-drug-reaction reporting details
Submitted by Anonymous (not verified) on 8 July 2024 - 16:50
QRD Appendix V - Adverse-drug-reaction reporting details
Agenda of the PRAC meeting 8-11 July 2024
Submitted by Anonymous (not verified) on 8 July 2024 - 16:45
Agenda of the PRAC meeting 8-11 July 2024
Submission dates
Submitted by Anonymous (not verified) on 8 July 2024 - 13:25
Submission dates
Focus group on submission predictability: Final report
Submitted by Anonymous (not verified) on 8 July 2024 - 13:20
Focus group on submission predictability: Final report